Atrial fibrillation from the pathologist's perspective

Cardiovascular Pathology

Volumn 23, Issue 2, 2014, Pages 71-84

  Corradi, Domenico ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Atrial fibrillation; Cardiomyocyte; Fibrosis; Genetics; Structural remodeling; Upstream therapy

Indexed keywords

ATRIAL FIBRILLATION; CARDIOMYOCYTE; FIBROSIS; GENETICS; STRUCTURAL REMODELING; UPSTREAM THERAPY;

ATRIAL FIBRILLATION; ATRIAL FUNCTION; ATRIAL REMODELING; GENETIC PREDISPOSITION TO DISEASE; HEART ATRIA; HUMANS; MYOCARDIUM; PHENOTYPE; PROGNOSIS; PULMONARY VEINS; RISK FACTORS;

EID: 84895074058     PISSN: 10548807     EISSN: 18791336     Source Type: Journal    
DOI: 10.1016/j.carpath.2013.12.001     Document Type: Review

References (220)

1. MC Wijffels, CJ Kirchhof, R Dorland, and MA Allessie Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats Circulation 92 1995 1954 1968
2. DM Lloyd-Jones, TJ Wang, EP Leip, MG Larson, D Levy, and RS Vasan et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study Circulation 110 2004 1042 1046 (Pubitemid 39319000)
3. WB Kannel, PA Wolf, EJ Benjamin, and D Levy Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates Am J Cardiol 82 1998 2N 9N (Pubitemid 28507114)
4. LY Chen, and WK Shen Epidemiology of atrial fibrillation: a current perspective Heart Rhythm 4 2007 S1 S6
5. V Fuster, LE Ryden, DS Cannom, HJ Crijns, AB Curtis, and KA Ellenbogen et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 2006 e257 e354
6. TM Syed, and JL Halperin Left atrial appendage closure for stroke prevention in atrial fibrillation: state of the art and current challenges Nat Clin Pract Cardiovasc Med 4 2007 428 435 (Pubitemid 47180327)
7. M Haïssaguerre, P Sanders, P Jaïs, M Hocini, D Shah, and J Clémenty Catheter ablation of atrial fibrillation: triggers and substrate D Zipes, Jalife Jeds, Cardiac electrophysiology: from cell to bedside 2004 W.B. Saunders Company Philadelphia 1028 1038
8. C Pappone, and S Rosanio Pulmonary vein isolation for atrial fibrillation D Zipes, Jalife Jeds, Cardiac electrophysiology: from cell to bedside 2004 W.B. Saunders Company Philadelphia 1039 1052
9. S Benussi, C Pappone, S Nascimbene, G Oreto, A Caldarola, and PL Stefano et al. A simple way to treat chronic atrial fibrillation during mitral valve surgery: the epicardial radiofrequency approach Eur J Cardiothorac Surg 17 2000 524 529 (Pubitemid 30256261)
10. MA Allessie, PA Boyden, AJ Camm, AG Kleber, MJ Lab, and MJ Legato et al. Pathophysiology and prevention of atrial fibrillation Circulation 103 2001 769 777 (Pubitemid 32144209)
11. D Corradi, S Callegari, R Maestri, S Benussi, and O Alfieri Structural remodeling in atrial fibrillation Nat Clin Pract Cardiovasc Med 5 2008 782 796
12. H Calkins, J Brugada, DL Packer, R Cappato, SA Chen, and HJ Crijns et al. HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation Heart Rhythm 4 2007 816 861 (Pubitemid 46850611)
13. JP Singh, and F Morady Patient selection and classification for atrial fibrillation ablation: thinking beyond duration Heart Rhythm 6 2009 1522 1525
14. MD Smit, and IC Van Gelder New treatment options for atrial fibrillation: towards patient tailored therapy Heart 97 2011 1796 1802
15. JE Saffitz, and RB Schuessler Altered atrial structure begets atrial fibrillation, but how? J Cardiovasc Electrophysiol 15 2004 1175 1176 (Pubitemid 39426046)
16. M Haissaguerre, P Jais, DC Shah, A Takahashi, M Hocini, and G Quiniou et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins N Engl J Med 339 1998 659 666 (Pubitemid 28402090)
17. MA Allessie, NM de Groot, RP Houben, U Schotten, E Boersma, and JL Smeets et al. Electropathological substrate of long-standing persistent atrial fibrillation in patients with structural heart disease: longitudinal dissociation Circ Arrhythm Electrophysiol 3 2010 606 615
18. A Verma The techniques for catheter ablation of paroxysmal and persistent atrial fibrillation: a systematic review Curr Opin Cardiol 26 2011 17 24
19. SA Chen, MH Hsieh, CT Tai, CF Tsai, VS Prakash, and WC Yu et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation Circulation 100 1999 1879 1886 (Pubitemid 29511141)
20. H Oral, BP Knight, H Tada, M Ozaydin, A Chugh, and S Hassan et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation Circulation 105 2002 1077 1081 (Pubitemid 34212617)
21. D Corradi, S Callegari, S Gelsomino, R Lorusso, and E Macchi Morphology and pathophysiology of target anatomical sites for ablation procedures in patients with atrial fibrillation: Part II: Pulmonary veins, caval veins, ganglionated plexi, and ligament of Marshall Int J Cardiol 168 2013 1769 1778
22. MP Smelley, and BP Knight Approaches to catheter ablation of persistent atrial fibrillation Heart Rhythm 6 2009 S33 S38
23. J Eckstein, S Verheule, NM de Groot, M Allessie, and U Schotten Mechanisms of perpetuation of atrial fibrillation in chronically dilated atria Prog Biophys Mol Biol 97 2008 435 451
24. SM Vaziri, MG Larson, EJ Benjamin, and D Levy Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study Circulation 89 1994 724 730 (Pubitemid 24056200)
25. BM Psaty, TA Manolio, LH Kuller, RA Kronmal, M Cushman, and LP Fried et al. Incidence of and risk factors for atrial fibrillation in older adults Circulation 96 1997 2455 2461 (Pubitemid 27425856)
26. GS Suarez, S Lampert, S Ravid, and B Lown Changes in left atrial size in patients with lone atrial fibrillation Clin Cardiol 14 1991 652 656
27. RS Phang, SM Isserman, D Karia, NG Pandian, MK Homoud, and MS Link et al. Echocardiographic evidence of left atrial abnormality in young patients with lone paroxysmal atrial fibrillation Am J Cardiol 94 2004 511 513 (Pubitemid 39120008)
28. RH Falk Etiology and complications of atrial fibrillation: insights from pathology studies Am J Cardiol 82 1998 10N 17N (Pubitemid 28507115)
29. M Rienstra, VE Hagens, DJ Van Veldhuisen, HA Bosker, JG Tijssen, and O Kamp et al. Clinical characteristics of persistent lone atrial fibrillation in the RACE study Am J Cardiol 94 2004 1486 1490 (Pubitemid 40268447)
30. M Thamilarasan, and AL Klein Factors relating to left atrial enlargement in atrial fibrillation: chicken or the egg hypothesis Am Heart J 137 1999 381 383 (Pubitemid 29124101)
31. J Ausma, M Wijffels, F Thone, L Wouters, M Allessie, and M Borgers Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat Circulation 96 1997 3157 3163 (Pubitemid 27500121)
32. J Woodcock-Mitchell, JJ Mitchell, RB Low, M Kieny, P Sengel, and L Rubbia et al. Alpha-smooth muscle actin is transiently expressed in embryonic rat cardiac and skeletal muscles Differentiation 39 1988 161 166 (Pubitemid 19082659)
33. J Ausma, M Wijffels, G van Eys, M Koide, F Ramaekers, and M Allessie et al. Dedifferentiation of atrial cardiomyocytes as a result of chronic atrial fibrillation Am J Pathol 151 1997 985 997 (Pubitemid 27424308)
34. D Corradi, S Callegari, S Benussi, R Maestri, P Pastori, and S Nascimbene et al. Myocyte changes and their left atrial distribution in patients with chronic atrial fibrillation related to mitral valve disease Hum Pathol 36 2005 1080 1089 (Pubitemid 41443259)
35. J Ausma, F Thone, GD Dispersyn, W Flameng, JL Vanoverschelde, and FC Ramaekers et al. Dedifferentiated cardiomyocytes from chronic hibernating myocardium are ischemia-tolerant Mol Cell Biochem 186 1998 159 168 (Pubitemid 28438558)
36. D Corradi, S Callegari, S Benussi, S Nascimbene, P Pastori, and S Calvi et al. Regional left atrial interstitial remodeling in patients with chronic atrial fibrillation undergoing mitral-valve surgery Virchows Arch 445 2004 498 505 (Pubitemid 39592754)
37. J Ausma, N Litjens, MH Lenders, H Duimel, F Mast, and L Wouters et al. Time course of atrial fibrillation-induced cellular structural remodeling in atria of the goat J Mol Cell Cardiol 33 2001 2083 2094 (Pubitemid 34073052)
38. J Ausma, HM van der Velden, MH Lenders, EP van Ankeren, HJ Jongsma, and FC Ramaekers et al. Reverse structural and gap-junctional remodeling after prolonged atrial fibrillation in the goat Circulation 107 2003 2051 2058 (Pubitemid 36506082)
39. D Corradi, S Callegari, R Maestri, S Benussi, S Bosio, and G De Palma et al. Heme oxygenase-1 expression in the left atrial myocardium of patients with chronic atrial fibrillation related to mitral valve disease: its regional relationship with structural remodeling Hum Pathol 39 2008 1162 1171
40. D Corradi, S Callegari, R Maestri, D Ferrara, D Mangieri, and R Alinovi et al. Differential structural remodeling of the left-atrial posterior wall in patients affected by mitral regurgitation with or without persistent atrial fibrillation: a morphological and molecular study J Cardiovasc Electrophysiol 23 2012 271 279
41. A Frustaci, C Chimenti, F Bellocci, E Morgante, MA Russo, and A Maseri Histological substrate of atrial biopsies in patients with lone atrial fibrillation Circulation 96 1997 1180 1184 (Pubitemid 27344221)
42. C Jellis, J Martin, J Narula, and TH Marwick Assessment of nonischemic myocardial fibrosis J Am Coll Cardiol 56 2010 89 97
43. DP Zipes, and RF Knope Electrical properties of the thoracic veins Am J Cardiol 29 1972 372 376
44. SY Ho, JA Cabrera, VH Tran, J Farre, RH Anderson, and D Sanchez-Quintana Architecture of the pulmonary veins: relevance to radiofrequency ablation Heart 86 2001 265 270 (Pubitemid 32800073)
45. YJ Chen, SA Chen, YC Chen, HI Yeh, P Chan, and MS Chang et al. Effects of rapid atrial pacing on the arrhythmogenic activity of single cardiomyocytes from pulmonary veins: implication in initiation of atrial fibrillation Circulation 104 2001 2849 2854 (Pubitemid 33126662)
46. TJ Wu, JJ Ong, CM Chang, RN Doshi, M Yashima, and HL Huang et al. Pulmonary veins and ligament of Marshall as sources of rapid activations in a canine model of sustained atrial fibrillation Circulation 103 2001 1157 1163 (Pubitemid 32200192)
47. H Honjo, MR Boyett, R Niwa, S Inada, M Yamamoto, and K Mitsui et al. Pacing-induced spontaneous activity in myocardial sleeves of pulmonary veins after treatment with ryanodine Circulation 107 2003 1937 1943 (Pubitemid 36444138)
48. C Rocken, B Peters, G Juenemann, W Saeger, HU Klein, and C Huth et al. Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation Circulation 106 2002 2091 2097 (Pubitemid 35192815)
49. D Feng, WD Edwards, JK Oh, K Chandrasekaran, M Grogan, and MW Martinez et al. Intracardiac thrombosis and embolism in patients with cardiac amyloidosis Circulation 116 2007 2420 2426 (Pubitemid 350145076)
50. A Bauer, AD McDonald, and JK Donahue Pathophysiological findings in a model of persistent atrial fibrillation and severe congestive heart failure Cardiovasc Res 61 2004 764 770 (Pubitemid 38249475)
51. S Cardin, D Li, N Thorin-Trescases, TK Leung, E Thorin, and S Nattel Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways Cardiovasc Res 60 2003 315 325 (Pubitemid 37412365)
52. C Aime-Sempe, T Folliguet, C Rucker-Martin, M Krajewska, S Krajewska, and M Heimburger et al. Myocardial cell death in fibrillating and dilated human right atria J Am Coll Cardiol 34 1999 1577 1586 (Pubitemid 29528674)
53. HS Duffy, and AL Wit Is there a role for remodeled connexins in AF? No simple answers J Mol Cell Cardiol 44 2008 4 13
54. C Vozzi, E Dupont, SR Coppen, HI Yeh, and NJ Severs Chamber-related differences in connexin expression in the human heart J Mol Cell Cardiol 31 1999 991 1003 (Pubitemid 29241535)
55. NJ Severs The cardiac gap junction and intercalated disc Int J Cardiol 26 1990 137 173 (Pubitemid 20035665)
56. JE Saffitz Connexins, conduction, and atrial fibrillation N Engl J Med 354 2006 2712 2714
57. AL Harris Emerging issues of connexin channels: biophysics fills the gap Q Rev Biophys 34 2001 325 472 (Pubitemid 34123306)
58. E Dupont, Y Ko, S Rothery, SR Coppen, M Baghai, and M Haw et al. The gap-junctional protein connexin40 is elevated in patients susceptible to postoperative atrial fibrillation Circulation 103 2001 842 849 (Pubitemid 32163883)
59. S Kostin, G Klein, Z Szalay, S Hein, EP Bauer, and J Schaper Structural correlate of atrial fibrillation in human patients Cardiovasc Res 54 2002 361 379 (Pubitemid 34327915)
60. U Wetzel, A Boldt, J Lauschke, J Weigl, P Schirdewahn, and A Dorszewski et al. Expression of connexins 40 and 43 in human left atrium in atrial fibrillation of different aetiologies Heart 91 2005 166 170
61. HM van der Velden, MJ van Kempen, MC Wijffels, M van Zijverden, WA Groenewegen, and MA Allessie et al. Altered pattern of connexin40 distribution in persistent atrial fibrillation in the goat J Cardiovasc Electrophysiol 9 1998 596 607 (Pubitemid 128721719)
62. L Polontchouk, JA Haefliger, B Ebelt, T Schaefer, D Stuhlmann, and U Mehlhorn et al. Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria J Am Coll Cardiol 38 2001 883 891 (Pubitemid 32835768)
63. T Nao, T Ohkusa, Y Hisamatsu, N Inoue, T Matsumoto, and J Yamada et al. Comparison of expression of connexin in right atrial myocardium in patients with chronic atrial fibrillation versus those in sinus rhythm Am J Cardiol 91 2003 678 683 (Pubitemid 36287457)
64. P Kanagaratnam, A Cherian, RD Stanbridge, B Glenville, NJ Severs, and NS Peters Relationship between connexins and atrial activation during human atrial fibrillation J Cardiovasc Electrophysiol 15 2004 206 216
65. JE Saffitz, KG Green, WJ Kraft, KB Schechtman, and KA Yamada Effects of diminished expression of connexin43 on gap junction number and size in ventricular myocardium Am J Physiol Heart Circ Physiol 278 2000 H1662 H1670
66. G Casaclang-Verzosa, BJ Gersh, and TS Tsang Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation J Am Coll Cardiol 51 2008 1 11
67. BA Schoonderwoerd, J Ausma, HJ Crijns, DJ Van Veldhuisen, EH Blaauw, and IC Van Gelder Atrial ultrastructural changes during experimental atrial tachycardia depend on high ventricular rate J Cardiovasc Electrophysiol 15 2004 1167 1174 (Pubitemid 39429501)
68. K Suzuki, S Imajoh, Y Emori, H Kawasaki, Y Minami, and S Ohno Calcium-activated neutral protease and its endogenous inhibitor. Activation at the cell membrane and biological function FEBS Lett 220 1987 271 277
69. BJ Brundel, RH Henning, HH Kampinga, IC Van Gelder, and HJ Crijns Molecular mechanisms of remodeling in human atrial fibrillation Cardiovasc Res 54 2002 315 324 (Pubitemid 34327911)
70. G Olivetti, R Abbi, F Quaini, J Kajstura, W Cheng, and JA Nitahara et al. Apoptosis in the failing human heart N Engl J Med 336 1997 1131 1141
71. B Burstein, and S Nattel Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation J Am Coll Cardiol 51 2008 802 809 (Pubitemid 351260071)
72. J Sadoshima, and S Izumo Autocrine secretion of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro Contrib Nephrol 118 1996 214 221
73. M Usui, K Egashira, H Tomita, M Koyanagi, M Katoh, and H Shimokawa et al. Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats Circulation 101 2000 305 310 (Pubitemid 30054158)
74. NJ Brown, and DE Vaughan Prothrombotic effects of angiotensin Adv Intern Med 45 2000 419 429
75. D Schroder, J Heger, HM Piper, and G Euler Angiotensin II stimulates apoptosis via TGF-beta1 signaling in ventricular cardiomyocytes of rat J Mol Med 84 2006 975 983 (Pubitemid 44655875)
76. CG Brilla, G Zhou, L Matsubara, and KT Weber Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone J Mol Cell Cardiol 26 1994 809 820 (Pubitemid 24223231)
77. N Hanna, S Cardin, TK Leung, and S Nattel Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure Cardiovasc Res 63 2004 236 244 (Pubitemid 38900838)
78. H Nakajima, HO Nakajima, O Salcher, AS Dittie, K Dembowsky, and S Jing et al. Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-beta(1) transgene in the heart Circ Res 86 2000 571 579 (Pubitemid 30165049)
79. U Schotten, HR Neuberger, and MA Allessie The role of atrial dilatation in the domestication of atrial fibrillation Prog Biophys Mol Biol 82 2003 151 162 (Pubitemid 36551213)
80. D MacKenna, SR Summerour, and FJ Villarreal Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis Cardiovasc Res 46 2000 257 263 (Pubitemid 30204597)
81. J Jalife Mechanisms of persistent atrial fibrillation Curr Opin Cardiol 29 2014 20 27
82. P Patel, H Dokainish, P Tsai, and N Lakkis Update on the association of inflammation and atrial fibrillation J Cardiovasc Electrophysiol 21 2010 1064 1070
83. L Hak, J Mysliwska, J Wieckiewicz, K Szyndler, J Siebert, and J Rogowski Interleukin-2 as a predictor of early postoperative atrial fibrillation after cardiopulmonary bypass graft (CABG) J Interferon Cytokine Res 29 2009 327 332
84. Y Guo, GY Lip, and S Apostolakis Inflammation in atrial fibrillation J Am Coll Cardiol 60 2012 2263 2270
85. I Liuba, H Ahlmroth, L Jonasson, A Englund, A Jonsson, and K Safstrom et al. Source of inflammatory markers in patients with atrial fibrillation Europace 10 2008 848 853 (Pubitemid 351882063)
86. GM Marcus, LM Smith, K Ordovas, MM Scheinman, AM Kim, and N Badhwar et al. Intracardiac and extracardiac markers of inflammation during atrial fibrillation Heart Rhythm 7 2010 149 154
87. PL Pellegrino, ND Brunetti, L De Gennaro, L Ziccardi, M Grimaldi, and MD Biase Inflammatory activation in an unselected population of subjects with atrial fibrillation: links with structural heart disease, atrial remodeling and recent onset Intern Emerg Med 8 2013 123 128
88. J Li, J Solus, Q Chen, YH Rho, G Milne, and CM Stein et al. Role of inflammation and oxidative stress in atrial fibrillation Heart Rhythm 7 2010 438 444
89. JY Youn, J Zhang, Y Zhang, H Chen, D Liu, and P Ping et al. Oxidative stress in atrial fibrillation: An emerging role of NADPH oxidase J Mol Cell Cardiol 62 2013 72 79
90. JP Chang, MC Chen, WH Liu, CH Yang, CJ Chen, and YL Chen et al. Atrial myocardial nox2 containing NADPH oxidase activity contribution to oxidative stress in mitral regurgitation: potential mechanism for atrial remodeling Cardiovasc Pathol 20 2011 99 106
91. YM Kim, TJ Guzik, YH Zhang, MH Zhang, H Kattach, and C Ratnatunga et al. A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation Circ Res 97 2005 629 636 (Pubitemid 41416331)
92. YM Kim, H Kattach, C Ratnatunga, R Pillai, KM Channon, and B Casadei Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery J Am Coll Cardiol 51 2008 68 74
93. J Zhang, JY Youn, AY Kim, RJ Ramirez, L Gao, and D Ngo et al. NOX4-dependent hydrogen peroxide overproduction in human atrial fibrillation and HL-1 atrial cells: relationship to hypertension Front Physiol 3 2012 140
94. RB Neuman, HL Bloom, I Shukrullah, LA Darrow, D Kleinbaum, and DP Jones et al. Oxidative stress markers are associated with persistent atrial fibrillation Clin Chem 53 2007 1652 1657 (Pubitemid 47340062)
95. E Babusikova, P Kaplan, J Lehotsky, M Jesenak, and D Dobrota Oxidative modification of rat cardiac mitochondrial membranes and myofibrils by hydroxyl radicals Gen Physiol Biophys 23 2004 327 335 (Pubitemid 39485254)
96. MJ Mihm, F Yu, CA Carnes, PJ Reiser, PM McCarthy, and DR Van Wagoner et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation Circulation 104 2001 174 180 (Pubitemid 32655834)
97. LP Lai, MJ Su, JL Lin, FY Lin, CH Tsai, and YS Chen et al. Down-regulation of L-type calcium channel and sarcoplasmic reticular Ca(2+)-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: an insight into the mechanism of atrial electrical remodeling J Am Coll Cardiol 33 1999 1231 1237
98. GR Li, and S Nattel Properties of human atrial ICa at physiological temperatures and relevance to action potential Am J Physiol 272 1997 H227 H235
99. CA Carnes, MK Chung, T Nakayama, H Nakayama, RS Baliga, and S Piao et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation Circ Res 89 2001 E32 E38
100. MS Wolin, and SA Gupte Novel roles for nox oxidases in cardiac arrhythmia and oxidized glutathione export in endothelial function Circ Res 97 2005 612 614 (Pubitemid 41416328)
101. S Basu, A Nozari, XL Liu, S Rubertsson, and L Wiklund Development of a novel biomarker of free radical damage in reperfusion injury after cardiac arrest FEBS Lett 470 2000 1 6 (Pubitemid 30155612)
102. KC Yang, and SC Dudley Oxidative stress and atrial fibrillation: finding a missing piece to the puzzle Circulation 128 2013 1724 1726
103. D Mozaffarian, JH Wu, MC de Oliveira Otto, CM Sandesara, RG Metcalf, and R Latini et al. Fish oil and post-operative atrial fibrillation: a meta-analysis of randomized controlled trials J Am Coll Cardiol 61 2013 2194 2196
104. AA Sovari, CA Rutledge, EM Jeong, E Dolmatova, D Arasu, and H Liu et al. Mitochondria oxidative stress, connexin43 remodeling, and sudden arrhythmic death Circ Arrhythm Electrophysiol 6 2013 623 631
105. BA Schoonderwoerd, MD Smit, L Pen, and IC Van Gelder New risk factors for atrial fibrillation: causes of 'not-so-lone atrial fibrillation' Europace 10 2008 668 673 (Pubitemid 351775282)
106. Y Lin, H Li, X Lan, X Chen, A Zhang, and Z Li Mechanism of and therapeutic strategy for atrial fibrillation associated with diabetes mellitus ScientificWorldJournal 2013 2013 209428
107. MR Movahed, M Hashemzadeh, and MM Jamal Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease Int J Cardiol 105 2005 315 318 (Pubitemid 41605083)
108. T Kato, T Yamashita, A Sekiguchi, K Sagara, M Takamura, and S Takata et al. What are arrhythmogenic substrates in diabetic rat atria? J Cardiovasc Electrophysiol 17 2006 890 894 (Pubitemid 44079750)
109. EJ Anderson, AP Kypson, E Rodriguez, CA Anderson, EJ Lehr, and PD Neufer Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart J Am Coll Cardiol 54 2009 1891 1898
110. T Kato, T Yamashita, A Sekiguchi, T Tsuneda, K Sagara, and M Takamura et al. AGEs-RAGE system mediates atrial structural remodeling in the diabetic rat J Cardiovasc Electrophysiol 19 2008 415 420 (Pubitemid 351457548)
111. M Mitasikova, H Lin, T Soukup, I Imanaga, and N Tribulova Diabetes and thyroid hormones affect connexin-43 and PKC-epsilon expression in rat heart atria Physiol Res 58 2009 211 217
112. I Klein, and S Danzi Thyroid disease and the heart Circulation 116 2007 1725 1735 (Pubitemid 47537847)
113. T Shimizu, S Koide, JY Noh, K Sugino, K Ito, and H Nakazawa Hyperthyroidism and the management of atrial fibrillation Thyroid 12 2002 489 493 (Pubitemid 34721545)
114. J Auer, P Scheibner, T Mische, W Langsteger, O Eber, and B Eber Subclinical hyperthyroidism as a risk factor for atrial fibrillation Am Heart J 142 2001 838 842 (Pubitemid 33016203)
115. S Fazio, EA Palmieri, G Lombardi, and B Biondi Effects of thyroid hormone on the cardiovascular system Recent Prog Horm Res 59 2004 31 50 (Pubitemid 41327146)
116. JA Sgarbi, FG Villaca, B Garbeline, HE Villar, and JH Romaldini The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities J Clin Endocrinol Metab 88 2003 1672 1677 (Pubitemid 36623386)
117. A Bielecka-Dabrowa, DP Mikhailidis, J Rysz, and M Banach The mechanisms of atrial fibrillation in hyperthyroidism Thyroid Res 2 2009 4
118. Y Zhang, EI Dedkov, D Teplitsky, NY Weltman, CJ Pol, and V Rajagopalan et al. Both hypothyroidism and hyperthyroidism increase atrial fibrillation inducibility in rats Circ Arrhythm Electrophysiol 6 2013 952 959
119. PO Ettinger, CF Wu, C De La Cruz, and Jr., Weisse AB, Ahmed SS, Regan TJ. Arrhythmias and the Holiday Heart: alcohol-associated cardiac rhythm disorders Am Heart J 95 1978 555 562 (Pubitemid 8329576)
120. CE Balbao, AA de Paola, and G Fenelon Effects of alcohol on atrial fibrillation: myths and truths Ther Adv Cardiovasc Dis 3 2009 53 63
121. S Kodama, K Saito, S Tanaka, C Horikawa, A Saito, and Y Heianza et al. Alcohol consumption and risk of atrial fibrillation: a meta-analysis J Am Coll Cardiol 57 2011 427 436
122. MR Piano, C Rosenblum, RJ Solaro, and D Schwertz Calcium sensitivity and the effect of the calcium sensitizing drug pimobendan in the alcoholic isolated rat atrium J Cardiovasc Pharmacol 33 1999 237 242 (Pubitemid 29066664)
123. H Denison, S Jern, R Jagenburg, C Wendestam, and S Wallerstedt Influence of increased adrenergic activity and magnesium depletion on cardiac rhythm in alcohol withdrawal Br Heart J 72 1994 554 560 (Pubitemid 24375750)
124. L Gould, CV Reddy, W Becker, KC Oh, and SG Kim Electrophysiologic properties of alcohol in man J Electrocardiol 11 1978 219 226 (Pubitemid 8387680)
125. P Steinbigler, R Haberl, B Konig, and G Steinbeck P-wave signal averaging identifies patients prone to alcohol-induced paroxysmal atrial fibrillation Am J Cardiol 91 2003 491 494 (Pubitemid 36183580)
126. MS Spach, and JM Kootsey The nature of electrical propagation in cardiac muscle Am J Physiol 244 1983 H3 H22
127. RJ Myerburg, K Nilsson, B Befeler, A Castellanos, and H Gelband Transverse spread and longitudinal dissociation in the distal A-V conducting system J Clin Invest 52 1973 885 895
128. J Eckstein, S Zeemering, D Linz, B Maesen, S Verheule, and A van Hunnik et al. Transmural conduction is the predominant mechanism of breakthrough during atrial fibrillation: evidence from simultaneous endo-epicardial high-density activation mapping Circ Arrhythm Electrophysiol 6 2013 334 341
129. NM de Groot, RP Houben, JL Smeets, E Boersma, U Schotten, and MJ Schalij et al. Electropathological substrate of longstanding persistent atrial fibrillation in patients with structural heart disease: epicardial breakthrough Circulation 122 2010 1674 1682
130. L Wolf Familial auricular fibrillation N Engl J Med 229 1943 396 398
131. SA Lubitz, C Ozcan, JW Magnani, S Kaab, EJ Benjamin, and PT Ellinor Genetics of atrial fibrillation: implications for future research directions and personalized medicine Circ Arrhythm Electrophysiol 3 2010 291 299
132. CS Fox, H Parise, RB D'Agostino, DM Lloyd-Jones, RS Vasan, and TJ Wang et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring JAMA 291 2004 2851 2855 (Pubitemid 38747806)
133. DO Arnar, S Thorvaldsson, TA Manolio, G Thorgeirsson, K Kristjansson, and H Hakonarson et al. Familial aggregation of atrial fibrillation in Iceland Eur Heart J 27 2006 708 712
134. IE Christophersen, LS Ravn, E Budtz-Joergensen, A Skytthe, S Haunsoe, and JH Svendsen et al. Familial aggregation of atrial fibrillation: a study in Danish twins Circ Arrhythm Electrophysiol 2 2009 378 383
135. PT Ellinor, DM Yoerger, JN Ruskin, and CA MacRae Familial aggregation in lone atrial fibrillation Hum Genet 118 2005 179 184 (Pubitemid 41672080)
136. D Darbar, KJ Herron, JD Ballew, A Jahangir, BJ Gersh, and WK Shen et al. Familial atrial fibrillation is a genetically heterogeneous disorder J Am Coll Cardiol 41 2003 2185 2192 (Pubitemid 36724265)
137. J Xiao, D Liang, and YH Chen The genetics of atrial fibrillation: from the bench to the bedside Annu Rev Genomics Hum Genet 12 2011 73 96
138. TM Olson, AE Alekseev, C Moreau, XK Liu, LV Zingman, and T Miki et al. KATP channel mutation confers risk for vein of Marshall adrenergic atrial fibrillation Nat Clin Pract Cardiovasc Med 4 2007 110 116 (Pubitemid 46165273)
139. IL Thibodeau, J Xu, Q Li, G Liu, K Lam, and JP Veinot et al. Paradigm of genetic mosaicism and lone atrial fibrillation: physiological characterization of a connexin 43-deletion mutant identified from atrial tissue Circulation 122 2010 236 244
140. MH Gollob, DL Jones, AD Krahn, L Danis, XQ Gong, and Q Shao et al. Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation N Engl J Med 354 2006 2677 2688
141. TM Olson, AE Alekseev, XK Liu, S Park, LV Zingman, and M Bienengraeber et al. Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation Hum Mol Genet 15 2006 2185 2191 (Pubitemid 43985509)
142. Y Yang, M Xia, Q Jin, S Bendahhou, J Shi, and Y Chen et al. Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation Am J Hum Genet 75 2004 899 905 (Pubitemid 39390498)
143. A Lundby, LS Ravn, JH Svendsen, S Hauns, SP Olesen, and N Schmitt KCNE3 mutation V17M identified in a patient with lone atrial fibrillation Cell Physiol Biochem 21 2008 47 54
144. LS Ravn, Y Aizawa, GD Pollevick, J Hofman-Bang, JM Cordeiro, and U Dixen et al. Gain of function in IKs secondary to a mutation in KCNE5 associated with atrial fibrillation Heart Rhythm 5 2008 427 435
145. K Hong, P Bjerregaard, I Gussak, and R Brugada Short QT syndrome and atrial fibrillation caused by mutation in KCNH2 J Cardiovasc Electrophysiol 16 2005 394 396
146. M Xia, Q Jin, S Bendahhou, Y He, MM Larroque, and Y Chen et al. A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation Biochem Biophys Res Commun 332 2005 1012 1019 (Pubitemid 40798187)
147. YH Chen, SJ Xu, S Bendahhou, XL Wang, Y Wang, and WY Xu et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation Science 299 2003 251 254 (Pubitemid 36125211)
148. R Otway, JI Vandenberg, G Guo, A Varghese, ML Castro, and J Liu et al. Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? J Am Coll Cardiol 49 2007 578 586 (Pubitemid 46177442)
149. S Das, S Makino, YF Melman, MA Shea, SB Goyal, and A Rosenzweig et al. Mutation in the S3 segment of KCNQ1 results in familial lone atrial fibrillation Heart Rhythm 6 2009 1146 1153
150. D Fatkin, C MacRae, T Sasaki, MR Wolff, M Porcu, and M Frenneaux et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease N Engl J Med 341 1999 1715 1724
151. P Sebillon, C Bouchier, LD Bidot, G Bonne, K Ahamed, and P Charron et al. Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations J Med Genet 40 2003 560 567 (Pubitemid 37046908)
152. DM Hodgson-Zingman, ML Karst, LV Zingman, DM Heublein, D Darbar, and KJ Herron et al. Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation N Engl J Med 359 2008 158 165 (Pubitemid 351962039)
153. X Zhang, S Chen, S Yoo, S Chakrabarti, T Zhang, and T Ke et al. Mutation in nuclear pore component NUP155 leads to atrial fibrillation and early sudden cardiac death Cell 135 2008 1017 1027
154. ZA Bhuiyan, MP van den Berg, JP van Tintelen, MT Bink-Boelkens, AC Wiesfeld, and M Alders et al. Expanding spectrum of human RYR2-related disease: new electrocardiographic, structural, and genetic features Circulation 116 2007 1569 1576 (Pubitemid 47511420)
155. H Watanabe, D Darbar, DW Kaiser, K Jiramongkolchai, S Chopra, and BS Donahue et al. Mutations in sodium channel beta1- and beta2-subunits associated with atrial fibrillation Circ Arrhythm Electrophysiol 2 2009 268 275
156. TM Olson, VV Michels, JD Ballew, SP Reyna, ML Karst, and KJ Herron et al. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation JAMA 293 2005 447 454
157. LA Naiche, Z Harrelson, RG Kelly, and VE Papaioannou T-box genes in vertebrate development Annu Rev Genet 39 2005 219 239 (Pubitemid 43011114)
158. CJ Boogerd, D Dooijes, A Ilgun, IB Mathijssen, R Hordijk, and IM van de Laar et al. Functional analysis of novel TBX5 T-box mutations associated with Holt-Oram syndrome Cardiovasc Res 88 2010 130 139
159. PT Ellinor, JT Shin, RK Moore, DM Yoerger, and CA MacRae Locus for atrial fibrillation maps to chromosome 6q14-16 Circulation 107 2003 2880 2883 (Pubitemid 36736626)
160. R Brugada, T Tapscott, GZ Czernuszewicz, AJ Marian, A Iglesias, and L Mont et al. Identification of a genetic locus for familial atrial fibrillation N Engl J Med 336 1997 905 911 (Pubitemid 27137190)
161. PG Volders, Q Zhu, C Timmermans, PM Eurlings, X Su, and YH Arens et al. Mapping a novel locus for familial atrial fibrillation on chromosome 10p11-q21 Heart Rhythm 4 2007 469 475 (Pubitemid 46610402)
162. CM Lewis, and J Knight Introduction to genetic association studies Cold Spring Harb Protoc 2012 2012 297 306
163. M Bedi, D McNamara, B London, and D Schwartzman Genetic susceptibility to atrial fibrillation in patients with congestive heart failure Heart Rhythm 3 2006 808 812 (Pubitemid 43960535)
164. C Fatini, E Sticchi, F Gensini, AM Gori, R Marcucci, and M Lenti et al. Lone and secondary nonvalvular atrial fibrillation: role of a genetic susceptibility Int J Cardiol 120 2007 59 65 (Pubitemid 47008994)
165. CT Tsai, LP Lai, JL Lin, FT Chiang, JJ Hwang, and MD Ritchie et al. Renin-angiotensin system gene polymorphisms and atrial fibrillation Circulation 109 2004 1640 1646 (Pubitemid 38451721)
166. LS Ravn, M Benn, BG Nordestgaard, AA Sethi, B Agerholm-Larsen, and GB Jensen et al. Angiotensinogen and ACE gene polymorphisms and risk of atrial fibrillation in the general population Pharmacogenet Genomics 18 2008 525 533 (Pubitemid 351769920)
167. C Fatini, E Sticchi, M Genuardi, F Sofi, F Gensini, and AM Gori et al. Analysis of minK and eNOS genes as candidate loci for predisposition to non-valvular atrial fibrillation Eur Heart J 27 2006 1712 1718 (Pubitemid 44026432)
168. JM Juang, YR Chern, CT Tsai, FT Chiang, JL Lin, and JJ Hwang et al. The association of human connexin 40 genetic polymorphisms with atrial fibrillation Int J Cardiol 116 2007 107 112
169. J Schreieck, S Dostal, N von Beckerath, A Wacker, M Flory, and S Weyerbrock et al. C825T polymorphism of the G-protein beta3 subunit gene and atrial fibrillation: association of the TT genotype with a reduced risk for atrial fibrillation Am Heart J 148 2004 545 550 (Pubitemid 39265132)
170. K Kato, M Oguri, T Hibino, K Yajima, H Matsuo, and T Segawa et al. Genetic factors for lone atrial fibrillation Int J Mol Med 19 2007 933 939
171. M Gaudino, F Andreotti, R Zamparelli, A Di Castelnuovo, G Nasso, and F Burzotta et al. The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? Circulation 108 Suppl 1 2003 II195 II199
172. LP Lai, MJ Su, HM Yeh, JL Lin, FT Chiang, and JJ Hwang et al. Association of the human minK gene 38G allele with atrial fibrillation: evidence of possible genetic control on the pathogenesis of atrial fibrillation Am Heart J 144 2002 485 490
173. MF Sinner, A Pfeufer, M Akyol, BM Beckmann, M Hinterseer, and A Wacker et al. The non-synonymous coding IKr-channel variant KCNH2-K897T is associated with atrial fibrillation: results from a systematic candidate gene-based analysis of KCNH2 (HERG) Eur Heart J 29 2008 907 914 (Pubitemid 351499476)
174. LS Ravn, J Hofman-Bang, U Dixen, SO Larsen, G Jensen, and S Haunso et al. Relation of 97T polymorphism in KCNE5 to risk of atrial fibrillation Am J Cardiol 96 2005 405 407 (Pubitemid 41058869)
175. LY Chen, JD Ballew, KJ Herron, RJ Rodeheffer, and TM Olson A common polymorphism in SCN5A is associated with lone atrial fibrillation Clin Pharmacol Ther 81 2007 35 41 (Pubitemid 46050865)
176. MT Nyberg, B Stoevring, ER Behr, LS Ravn, WJ McKenna, and M Christiansen The variation of the sarcolipin gene (SLN) in atrial fibrillation, long QT syndrome and sudden arrhythmic death syndrome Clin Chim Acta 375 2007 87 91 (Pubitemid 44584225)
177. WS Bush, and JH Moore Chapter 11: Genome-wide association studies PLoS Comput Biol 8 2012 e1002822
178. PT Ellinor, KL Lunetta, CM Albert, NL Glazer, MD Ritchie, and AV Smith et al. Meta-analysis identifies six new susceptibility loci for atrial fibrillation Nat Genet 44 2012 670 675
179. PT Ellinor, KL Lunetta, NL Glazer, A Pfeufer, A Alonso, and MK Chung et al. Common variants in KCNN3 are associated with lone atrial fibrillation Nat Genet 42 2010 240 244
180. DF Gudbjartsson, DO Arnar, A Helgadottir, S Gretarsdottir, H Holm, and A Sigurdsson et al. Variants conferring risk of atrial fibrillation on chromosome 4q25 Nature 448 2007 353 357 (Pubitemid 47080348)
181. EJ Benjamin, KM Rice, DE Arking, A Pfeufer, C van Noord, and AV Smith et al. Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry Nat Genet 41 2009 879 881
182. S Kaab, D Darbar, C van Noord, J Dupuis, A Pfeufer, and C Newton-Cheh et al. Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation Eur Heart J 30 2009 813 819
183. C Viviani Anselmi, V Novelli, R Roncarati, A Malovini, R Bellazzi, and R Bronzini et al. Association of rs2200733 at 4q25 with atrial flutter/fibrillation diseases in an Italian population Heart 94 2008 1394 1396
184. L Shi, C Li, C Wang, Y Xia, G Wu, and F Wang et al. Assessment of association of rs2200733 on chromosome 4q25 with atrial fibrillation and ischemic stroke in a Chinese Han population Hum Genet 126 2009 843 849
185. DF Gudbjartsson, H Holm, S Gretarsdottir, G Thorleifsson, GB Walters, and G Thorgeirsson et al. A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke Nat Genet 41 2009 876 878
186. MS Olesen, MW Nielsen, S Haunso, and JH Svendsen Atrial fibrillation: the role of common and rare genetic variants Eur J Hum Genet 2013 10.1038/ejhg.2013.139 [Epub ahead of print]
187. C Napolitano The contradictory genetics of atrial fibrillation: the growing gap between knowledge and clinical implications J Cardiovasc Electrophysiol 24 2013 570 572
188. JT Delaney, JM Jeff, NJ Brown, M Pretorius, HE Okafor, and D Darbar et al. Characterization of genome-wide association-identified variants for atrial fibrillation in African Americans PLoS One 7 2012 e32338
189. S Mahida, and PT Ellinor New advances in the genetic basis of atrial fibrillation J Cardiovasc Electrophysiol 23 2012 1400 1406
190. S Mahida, SA Lubitz, M Rienstra, DJ Milan, and PT Ellinor Monogenic atrial fibrillation as pathophysiological paradigms Cardiovasc Res 89 2011 692 700
191. DP Zipes, AJ Camm, M Borggrefe, AE Buxton, B Chaitman, and M Fromer et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 2006 e385 e484
192. DG Wyse, AL Waldo, JP DiMarco, MJ Domanski, Y Rosenberg, and EB Schron et al. A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833 (Pubitemid 35417773)
193. SD Corley, AE Epstein, JP DiMarco, MJ Domanski, N Geller, and HL Greene et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study Circulation 109 2004 1509 1513 (Pubitemid 38420179)
194. P Assayag, F Carre, B Chevalier, C Delcayre, P Mansier, and B Swynghedauw Compensated cardiac hypertrophy: arrhythmogenicity and the new myocardial phenotype. I. Fibrosis Cardiovasc Res 34 1997 439 444 (Pubitemid 27272662)
195. D Corradi, S Callegari, R Maestri, S Benussi, S Bosio, and G De Palma et al. Heme oxygenase-1 expression in the left atrial myocardium of patients with chronic atrial fibrillation related to mitral valve disease: its regional relationship with structural remodelling Hum Pathol 39 2008 1162 1171
196. I Savelieva, N Kakouros, A Kourliouros, and AJ Camm Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention Europace 13 2011 308 328
197. I Savelieva, N Kakouros, A Kourliouros, and AJ Camm Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention Europace 13 2011 610 625
198. G Huang, JB Xu, JX Liu, Y He, XL Nie, and Q Li et al. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis Eur J Clin Invest 41 2011 719 733
199. R Bhuriya, M Singh, A Sethi, J Molnar, A Bahekar, and PP Singh et al. Prevention of recurrent atrial fibrillation with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers: a systematic review and meta-analysis of randomized trials J Cardiovasc Pharmacol Ther 16 2011 178 184
200. D Li, K Shinagawa, L Pang, TK Leung, S Cardin, and Z Wang et al. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure Circulation 104 2001 2608 2614 (Pubitemid 33104801)
201. Y Li, W Li, B Yang, W Han, D Dong, and J Xue et al. Effects of Cilazapril on atrial electrical, structural and functional remodeling in atrial fibrillation dogs J Electrocardiol 40 2007 e1 e6
202. M Sakabe, A Fujiki, K Nishida, M Sugao, H Nagasawa, and T Tsuneda et al. Enalapril prevents perpetuation of atrial fibrillation by suppressing atrial fibrosis and over-expression of connexin43 in a canine model of atrial pacing-induced left ventricular dysfunction J Cardiovasc Pharmacol 43 2004 851 859 (Pubitemid 38679607)
203. Y Shi, D Li, JC Tardif, and S Nattel Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure Cardiovasc Res 54 2002 456 461 (Pubitemid 34327924)
204. K Kumagai, H Nakashima, H Urata, N Gondo, K Arakawa, and K Saku Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation J Am Coll Cardiol 41 2003 2197 2204 (Pubitemid 36724267)
205. A Goette, A Bukowska, and U Lendeckel Non-ion channel blockers as anti-arrhythmic drugs (reversal of structural remodeling) Curr Opin Pharmacol 7 2007 219 224 (Pubitemid 46404738)
206. RS Williams, JA deLemos, V Dimas, J Reisch, JA Hill, and RH Naseem Effect of spironolactone on patients with atrial fibrillation and structural heart disease Clin Cardiol 34 2011 415 419
207. P Milliez, N Deangelis, C Rucker-Martin, A Leenhardt, E Vicaut, and E Robidel et al. Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction Eur Heart J 26 2005 2193 2199 (Pubitemid 41408006)
208. L Fauchier, N Clementy, and D Babuty Statin therapy and atrial fibrillation: systematic review and updated meta-analysis of published randomized controlled trials Curr Opin Cardiol 28 2013 7 18
209. I Savelieva, and J Camm Statins and polyunsaturated fatty acids for treatment of atrial fibrillation Nat Clin Pract Cardiovasc Med 5 2008 30 41
210. I Savelieva, A Kourliouros, and J Camm Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance Naunyn Schmiedebergs Arch Pharmacol 381 2010 1 13
211. A Shiroshita-Takeshita, BJ Brundel, B Burstein, TK Leung, H Mitamura, and S Ogawa et al. Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure Cardiovasc Res 74 2007 75 84 (Pubitemid 46366949)
212. J Mariani, HC Doval, D Nul, S Varini, H Grancelli, and D Ferrante et al. N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials J Am Heart Assoc 2 2013 e005033
213. D Mozaffarian, R Marchioli, A Macchia, MG Silletta, P Ferrazzi, and TJ Gardner et al. Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial JAMA 308 2012 2001 2011
214. G Laurent, G Moe, X Hu, B Holub, H Leong-Poi, and J Trogadis et al. Long chain n-3 polyunsaturated fatty acids reduce atrial vulnerability in a novel canine pacing model Cardiovasc Res 77 2008 89 97 (Pubitemid 351195152)
215. A Leaf, JX Kang, YF Xiao, and GE Billman Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils Circulation 107 2003 2646 2652 (Pubitemid 36667234)
216. T Koyama, H Tada, Y Sekiguchi, T Arimoto, H Yamasaki, and K Kuroki et al. Prevention of atrial fibrillation recurrence with corticosteroids after radiofrequency catheter ablation: a randomized controlled trial J Am Coll Cardiol 56 2010 1463 1472
217. J Halonen, P Halonen, O Jarvinen, P Taskinen, T Auvinen, and M Tarkka et al. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial JAMA 297 2007 1562 1567 (Pubitemid 46588369)
218. AJ Camm, P Kirchhof, GY Lip, U Schotten, I Savelieva, and S Ernst et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Europace 12 2010 1360 1420
219. D Corradi, S Callegari, S Gelsomino, R Lorusso, and E Macchi Morphology and pathophysiology of target anatomical sites for ablation procedures in patients with atrial fibrillation. Part I: Atrial structures (atrial myocardium and coronary sinus) Int J Cardiol 168 2013 1758 1768
220. A Pump, L Di Biase, J Price, P Mohanty, R Bai, and P Santangeli et al. Efficacy of catheter ablation in nonparoxysmal atrial fibrillation patients with severe enlarged left atrium and its impact on left atrial structural remodeling J Cardiovasc Electrophysiol 24 2013 1224 1231